4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-000608
CHIEF ACCOUNTING OFFICER sold 16,670 shares at $19.17 ($319,564)
- CHIEF ACCOUNTING OFFICER acquired 16,670 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-01-02 | Option exercise 10b5-1 | +16,670 | $13.88 | $231,380 | 33,675 | D: show line 1 in the form |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-01-02 | Sale 10b5-1 | −16,670 | $19.17 | $319,564 | 17,005 | D: show line 2 in the form |
| Open-market sales · 16,670 sh · avg $19.17 · $319,564 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-01-02 | Option exercise · Share Option 10b5-1 | −16,670 | 4,014 | D: show line 3 in the form |
Loading xslF345X05/form4-01042024_040110.xml…